Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$12,534,362
+$8,254,268 QoQ
Shares Held
520,530
+241.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#369
of 2,821 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fideuram Asset Management (Ireland) dac holds $203,528,260 across 10 Drug Manufacturers - General names. PFE ranks #8 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,491 | $35,372,393 | |
| 2 | JNJ |
Johnson & Johnson
|
136,308 | $34,618,142 | |
| 3 | ABBV |
AbbVie Inc.
|
119,179 | $29,990,203 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
201,922 | $25,510,825 | |
| 5 | MRK |
Merck & Co., Inc.
|
149,491 | $19,209,593 | |
| 6 | AZN |
Astrazeneca PLC
|
93,902 | $17,805,697 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
242,950 | $13,998,779 | |
| 8 | PFE |
Pfizer Inc
This page
|
520,530 | $12,534,362 |
All Filings in PFE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,534,362 | 520,530 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $4,280,094 | 152,425 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $1,995,909 | 80,157 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||